Annual Total Long Term Liabilities
$3.88 M
-$1.88 M-32.58%
December 31, 2022
Summary
- As of February 10, 2025, EUCR annual total long term liabilities is $3.88 million, with the most recent change of -$1.88 million (-32.58%) on December 31, 2022.
- During the last 3 years, EUCR annual total long term liabilities has fallen by -$6.41 million (-62.25%).
Performance
EUCR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$3.88 M
+$72.80 K+1.91%
December 31, 2022
Summary
- As of February 10, 2025, EUCR quarterly total long term liabilities is $3.88 million, with the most recent change of +$72.80 thousand (+1.91%) on December 31, 2022.
- Over the past year, EUCR quarterly long term liabilities has dropped by -$1.88 million (-32.58%).
Performance
EUCR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
EUCR Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.6% | -32.6% |
| 3 y3 years | -62.3% | +100.0% |
| 5 y5 years | -62.3% | +100.0% |
EUCR Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.6% | at low | -32.6% | -1.9% |
| 5 y | 5-year | -62.3% | at low | -52.6% | -100.0% |
| alltime | all time | -62.3% | at low | -52.6% | -100.0% |
Eucrates Biomedical Acquisition Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $3.88 M(-32.6%) | $3.88 M(+1.9%) |
| Sep 2022 | - | $3.81 M(-2.6%) |
| Jun 2022 | - | $3.91 M(-10.1%) |
| Mar 2022 | - | $4.35 M(-24.4%) |
| Dec 2021 | $5.76 M | $5.76 M(-7.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $6.23 M(-16.1%) |
| Jun 2021 | - | $7.43 M(-9.3%) |
| Mar 2021 | - | $8.19 M(>+9900.0%) |
| Dec 2020 | $10.29 M | - |
| Sep 2020 | - | $0.00(0.0%) |
| Aug 2020 | - | $0.00 |
FAQ
- What is Eucrates Biomedical Acquisition annual total long term liabilities?
- What is the all time high annual total long term liabilities for Eucrates Biomedical Acquisition?
- What is Eucrates Biomedical Acquisition annual total long term liabilities year-on-year change?
- What is Eucrates Biomedical Acquisition quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Eucrates Biomedical Acquisition?
- What is Eucrates Biomedical Acquisition quarterly long term liabilities year-on-year change?
What is Eucrates Biomedical Acquisition annual total long term liabilities?
The current annual total long term liabilities of EUCR is $3.88 M
What is the all time high annual total long term liabilities for Eucrates Biomedical Acquisition?
Eucrates Biomedical Acquisition all-time high annual total long term liabilities is $10.29 M
What is Eucrates Biomedical Acquisition annual total long term liabilities year-on-year change?
Over the past year, EUCR annual total long term liabilities has changed by -$1.88 M (-32.58%)
What is Eucrates Biomedical Acquisition quarterly total long term liabilities?
The current quarterly long term liabilities of EUCR is $3.88 M
What is the all time high quarterly long term liabilities for Eucrates Biomedical Acquisition?
Eucrates Biomedical Acquisition all-time high quarterly total long term liabilities is $8.19 M
What is Eucrates Biomedical Acquisition quarterly long term liabilities year-on-year change?
Over the past year, EUCR quarterly total long term liabilities has changed by -$1.88 M (-32.58%)